Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis.

Abstract

The article "Eculizumab improves fatigue in refractory generalized myasthenia gravis", written by "Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny O'Brien, Kaushik Patra, James F. Howard Jr. and The REGAIN Study Group" was originally published electronically on the publisher's internet portal (currently SpringerLink) on 23 March 2019 without open access.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1007/s11136-019-02204-x

Publication Info

Andersen, Henning, Renato Mantegazza, Jing Jing Wang, Fanny O'Brien, Kaushik Patra, James F Howard and undefined REGAIN Study Group (2019). Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 28(8). p. 2255. 10.1007/s11136-019-02204-x Retrieved from https://hdl.handle.net/10161/28444.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.